GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (STU:BSX) » Definitions » Valuation Rank

Boston Scientific (STU:BSX) Valuation Rank


View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Boston Scientific Valuation Rank Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Boston Scientific Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (STU:BSX) » Definitions » Valuation Rank
Comparable Companies
SYK MDT ABT EW DXCM ZBH STE PODD GMED PEN XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH LSE:SN. BIO MASI BRKR
Traded in Other Exchanges
BSX:USA BSX:Mexico 1BSX:Italy 0HOY:UK BSX:Germany BSX:Germany B1SX34:Brazil BSXC:Austria
Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Website
https://www.bostonscientific.com
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.